That’s not quite my question. My question is, did CGB approach Biohealth or did Biohealth approach CGB with a proposal?
Because if CGB approached Biohealth then I’d like to know why? Was the approach running concurrently with medcann proposal OR did they realise medcann wasn’t worth it and tried to come up with something new OR did medcann maybe not want to go ahead?
CGB Price at posting:
3.7¢ Sentiment: Sell Disclosure: Held